Limited time75% off all plans
Get the app

Diphtheria, tetanus, pertussis

On this page

Diphtheria - The Strangling Angel

  • Organism: Corynebacterium diphtheriae (Gram-positive, club-shaped rod).
  • Pathophysiology: Exotoxin encoded by a β-prophage inhibits protein synthesis.
  • Clinical Features:
    • Local: Sore throat, fever, and a thick, gray, adherent pseudomembrane on the tonsils/pharynx that bleeds when scraped.
    • Systemic: "Bull neck" from cervical adenopathy, myocarditis, and neuropathies.
  • Diagnosis: Culture on Tellurite or Loeffler's agar; Elek's test for toxin production.
  • Treatment: Urgent administration of diphtheria antitoxin plus antibiotics (e.g., erythromycin or penicillin).

⭐ The exotoxin inactivates Elongation Factor-2 (EF-2) via ADP-ribosylation, halting protein synthesis.

Diphtheria pseudomembrane in pharynx

Tetanus - The Rigid Smile

  • Organism: Clostridium tetani - Gram-positive, spore-forming rod (tennis racket appearance), obligate anaerobe found in soil.
  • Toxin: Tetanospasmin, a protease that travels via retrograde axonal transport to the spinal cord.

Mechanism: Tetanospasmin cleaves synaptobrevin (a SNARE protein), irreversibly blocking the release of inhibitory neurotransmitters (GABA and glycine) from Renshaw cells.

  • Clinical: Presents with spastic paralysis.
    • Trismus (lockjaw) is a common early sign.
    • Risus sardonicus (rigid, grinning smile).
    • Opisthotonus (arched back).

Ablett Classification of Tetanus Severity

Pertussis - The 100-Day Cough

  • Organism: Bordetella pertussis, a gram-negative coccobacillus.
  • Transmission: Respiratory droplets; highly contagious.
  • Clinical Stages:
    • Catarrhal (1-2 wks): Nonspecific symptoms, highest infectivity.
    • Paroxysmal (2-8 wks): Inspiratory "whoop," post-tussive emesis.
    • Convalescent (1-3 mos): Gradual symptom resolution.
  • Diagnosis: PCR or culture (nasopharyngeal swab).
  • Treatment: Macrolides (e.g., Azithromycin).

Exam Favorite: Pertussis toxin ADP-ribosylates and inactivates Gi proteins, preventing them from inhibiting adenylate cyclase. The resulting surge in cAMP causes massive lymphocytosis by preventing lymphocyte entry into lymph nodes.

DTPH Vaccines - Acellular Shield

  • DTaP (Diphtheria, Tetanus, acellular Pertussis): Primary series for children <7 years.
  • Tdap (Tetanus, diphtheria, acellular Pertussis): Booster for adolescents & adults; features lower diphtheria/pertussis antigen dose.
    • Administer one dose, then Td booster every 10 years.
  • Mechanism: Toxoid-based vaccines that stimulate humoral immunity against bacterial toxins.

⭐ Tdap is recommended during each pregnancy (27-36 weeks) to confer passive immunity to the neonate.

Tetanus vaccine schedule by age group (DTaP, Tdap, Td)

High‑Yield Points - ⚡ Biggest Takeaways

  • Diphtheria toxin inactivates Elongation Factor-2 (EF-2) via ADP-ribosylation, halting protein synthesis.
  • Tetanus toxin cleaves SNARE proteins, blocking the release of inhibitory neurotransmitters GABA and glycine, causing spastic paralysis.
  • Pertussis toxin ADP-ribosylates Gi, leading to increased cAMP levels and the characteristic "whooping cough".
  • Key presentations: Diphtheria's pharyngeal pseudomembrane and myocarditis; Tetanus's trismus (lockjaw).
  • The DTaP/Tdap vaccine uses toxoids for diphtheria/tetanus and acellular pertussis antigens.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS
Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Everything you need for USMLE prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE